Tyra Biosciences Inc.

NASDAQ: TYRA · Real-Time Price · USD
10.73
0.03 (0.28%)
At close: Aug 15, 2025, 3:59 PM
10.73
0.00%
After-hours: Aug 15, 2025, 04:34 PM EDT

Tyra Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-86.48M -69.13M -55.33M -26.29M
Depreciation & Amortization
519K 353K 296K 140K
Stock-Based Compensation
22.8M 13.53M 10.59M 2.89M
Other Working Capital
n/a -3.01M -8.2M -1.97M
Other Non-Cash Items
-5.88M -1.24M 3K 3K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-729K 6.36M -5.85M -481K
Operating Cash Flow
-69.77M -50.14M -50.28M -23.75M
Capital Expenditures
-664K -770K -559K -661K
Cash Acquisitions
n/a n/a n/a 16K
Purchase of Investments
-263.62M -143.84M n/a n/a
Sales Maturities Of Investments
165.88M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 16.00
Investing Cash Flow
-98.4M -144.6M -559K -645K
Debt Repayment
n/a n/a n/a -9K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.54M 632K 514K
Financial Cash Flow
202.14M 1.54M 632.00 311.35M
Net Cash Flow
33.96M -193.21M -50.21M 286.96M
Free Cash Flow
-70.44M -50.91M -50.84M -24.41M